drugset / Trial / NCT01014429
Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of NMS-1286937, a polo-like-kinase 1 inhibitor, in patients with advanced metastatic solid tumor.
Timeline
- Start
- 2009-11
- Primary completion
- 2011-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Onvansertib | Small molecule | — | — |
Indications
No indication recorded.